Abiomed
ABMD
#1112
Rank
ยฃ13.65 B
Marketcap
ยฃ302.76
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Revenue for Abiomed (ABMD)

Revenue in 2022 (TTM): ยฃ0.86 Billion

According to Abiomed's latest financial reports the company's current revenue (TTM ) is ยฃ0.85 Billion. In 2021 the company made a revenue of ยฃ0.74 Billion an increase over the revenue in the year 2020 that were of ยฃ0.59 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Abiomed from 2013 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) ยฃ0.86 B16.45%
2021 ยฃ0.74 B24.61%
2020 ยฃ0.59 B-7.04%
2019 ยฃ0.64 B10.53%
2018 ยฃ0.58 B44.21%
2017 ยฃ0.40 B19.8%
2016 ยฃ0.33 B64.25%
2015 ยฃ0.20 B49.39%
2014 ยฃ0.13 B27.69%
2013 ยฃ0.10 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ2.40 B 181.71%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ12.10 B 1,317.75%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.35 B-58.33%๐Ÿ‡บ๐Ÿ‡ธ USA